A novel approach to left atrial appendage exclusion: The WATCHMAN device

Cardiology in Review

Volumn 18, Issue 5, 2010, Pages 230-233

  Gorodnitskiy, Alexander ^a   Lucariello, Richard J ^b   Aizer, Anthony ^c   Coppola, John T ^d  

^a LANKENAU HOSPITAL   (United States)

^b BOSTON COLLEGE   (United States)

^c NEW YORK UNIVERSITY   (United States)

^d NEW YORK UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

HEPARIN; WARFARIN;

AIR EMBOLISM; ANTICOAGULANT THERAPY; DEVICE THERAPY; FEASIBILITY STUDY; FEMORAL VEIN; HEART ATRIUM APPENDAGE; HEART ATRIUM FIBRILLATION; HEART ATRIUM THROMBOSIS; HEART SURGERY; HOSPITALIZATION; HUMAN; IMPLANT; IMPLANTATION; INTERNATIONAL NORMALIZED RATIO; LEFT ATRIAL APPENDAGE; OUTCOME ASSESSMENT; PATIENT SAFETY; PERICARDIAL EFFUSION; REVIEW; RISK ASSESSMENT; STROKE; SURGICAL APPROACH; SURGICAL TECHNIQUE; THROMBOGENESIS; TRANSESOPHAGEAL ECHOCARDIOGRAPHY;

ANTICOAGULANTS; ATRIAL FIBRILLATION; HUMANS; RISK FACTORS; SEPTAL OCCLUDER DEVICE; STROKE; THROMBOEMBOLISM; WARFARIN;

EID: 77955874047     PISSN: 10615377     EISSN: None     Source Type: Journal    
DOI: 10.1097/CRD.0b013e3181e53abb     Document Type: Review

References (23)

1. Estes NA. Catheter ablation of atrial fibrillation: is the burn worth the buck? J Cardiovasc Electrophysiol. 2007;18:914-916.
2. Prystowsy EN, Benson DW Jr, Fuster V, et al. Management of patients with atrial fibrillation. A statement for healthcare professionals. From the Subcommittee on Electrocardiography and Electrophysiology, American Heart Association. Circulation. 1996;93:1262-1277.
3. Cooper NJ, Sutton AJ, Lu G, et al. Mixed comparison of stroke prevention treatments in individuals with nonrheumatic atrial fibrillation. Arch Intern Med. 2006;166:1269-1275.
4. Gage BF, Waterman AD, Shannon W, et al. Validation of clinical classification schemes for predicting stroke: results from the National Registry of Atrial Fibrillation. JAMA. 2001;285:2864-2870.
5. Weinberger J, Frishman WH. Drug therapy of neurovascular disease. In: Frishman WH, Sica DA, eds. Cardiovascular Pharmacotherapeutics. 3rd ed. Minneapolis, MN: McGraw-Hill; 2010.
6. The Stroke Prevention in Atrial Fibrillation Investigators Committee on Echocardiography. Transesophageal echocardiography correlates of throm-boembolism in high-risk patients which nonvalvular atrial fibrillation. Ann Intern Med. 1998;128:639-647.
7. Blackshear JL, Odell JA. Appendage obliteration to reduce stroke in cardiac surgical patients with atrial fibrillation. Ann Thorac Surg. 1996; 61:755-759.
8. Stoddard MF, Dawkins PR, Prince CR, et al. Left atrial appendage thrombus is not uncommon in patients with acute atrial fibrillation and a recent embolic event: a transesophageal echocardiography study. J Am Coll Cardiol. 1995; 25:452-459.
9. Al-Saady NM, Obel OA, Camm AJ. Left atrial appendage: structure, function, and role in the thromboembolism. Heart. 1999;82:547-554.
10. Bonow RO, Carabello BA, Kanu C, et al. ACC/AHA 2006 guidelines for the management of patients with valvular heart disease: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (writing committee to revise the 1998 guidelines for the management of patients with valvular heart disease) developed in collaboration with the Society of Cardiovascular Anesthesiologists endorsed by the Society for Cardiovascular Angiography and Interventions and the Society of Thoracic Surgeons. JAm Coll Cardiol. 2006;48:e1-e148.
11. Cox JL. The surgical treatment of atrial fibrillation. IV. Surgical technique. JThorac Cardiovasc Surg. 1991;101:584-592.
12. Gaynor SL, Schuessler RB, Bailey MS, et al. Surgical treatment of atrial fibrillation: predicators of late recurrence. J Thorac Cardiovasc Surg. 2005; 129:104-111.
13. Calkins H, Brugada J, Packer DL, et al. HRS/EHRA/ECAS expert consensus statement on catheter and surgical ablation of atrial fibrillation: recommendations for personnel, policy, procedures and follow-up. Heart Rhythm. 2007;4:816-861.
14. Katz ES, Tsiamtsiouris T, Applebaum RM, et al. Surgical left atrial appendage ligation is frequently incomplete: a transesophageal echocardiograhic study. J Am Coll Cardiol. 2000;36:468-471.
15. Sievert H, Lesh MD, Trepels T, et al. Percutaneous left atrial appendage transcatheter occlusion to prevent stroke in high-risk patients with atrial fibrillation: early clinical experience. Circulation. 2002;105:1887-1889.
16. Nakai T, Lesh MD, Gerstenfeld EP, et al. Percutaneous left atrial appendage occlusion (PLAATO) for preventing cardioembolism: first experience in canine model. Circulation. 2002;105:2217-2222.
17. El-Chami MF, Grow P, Eilen D, et al. Clinical outcomes three years after PLAATO implantation. Catheter Cardiovasc Interv. 2007;69:704-707.
18. Block PC, Burstein S, Casale PN, et al. Percutaneous left atrial appendage occlusion for patients in atrial fibrillation suboptimal for warfarin therapy: 5-year results of the PLAATO (Percutaneous Left Atrial Appendage Trans-catheter Occlusion) Study. JACC Cardiovasc Interv. 2009;2:594-600.
19. Mobius-Winkler S, Schuler C, Sick PB, et al. Interventional treatments for stroke prevention in atrial fibrillation with emphasis upon the WATCHMAN device. Curr Opin Neurol. 2008;21:64-69.
20. Meier B, Palacios I, Windecker S, et al. Transcatheter left atrial appendage occlusion with Amplatzer devices to obviate anticoagulation in patients with atrial fibrillation. Catheter Cardiovasc Interv. 2003;60:417-422.
21. Sick PB, Schuler G, Hauptman KE, et al. Initial worldwide experience with the WATCHMAN left atrial appendage system for stroke prevention in atrial fibrillation. JAm Coll Cardiol. 2007;49:1490-1495.
22. Holmes DR, Reddy VY, Turi ZG, et al. Percutaneous closure of the left atrial appendage versus warfarin therapy for prevention of stroke in patients with atrial fibrillation: randomized non-inferiority trial. Lancet. 2009;374:534-542.
23. Maisel WH. Left atrial appendage occlusion-closure or just the beginning? N Engl J Med. 2009;360:2601-2603.